MiniMed Group (MMED) has for a proposed Nasdaq IPO.
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...
News-Medical.Net on MSN
Peptide-based platform marks a major step toward needle-free diabetes care
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback